Evaluating a Distance Learning Asthma Education Program for Pediatricians (The DALI Study)
Evaluating a Distance Learning Asthma Education Program for Pediatricians (The DALI Study)
The National Heart, Lung, and Blood Institute (NHLBI) has established guidelines for treating
 people with asthma. This study will evaluate the effectiveness of a distance learning program
 that aims to educate doctors on these guidelines, specifically the use of inhaled
 corticosteroids to treat asthma in pediatric patients.
Asthma is a long-term lung disease that affects more than 22 million people in the United
 States. Symptoms include wheezing, chest tightness, shortness of breath, and coughing.
 Inhaled corticosteroids are a common medication used to treat asthma. NHLBI has established
 guidelines for doctors to reference when treating people with asthma. Study researchers
 previously evaluated a distance learning program aimed to educate doctors on the NHLBI
 guidelines and to improve pediatrician adherence to the guideline recommendations for the use
 of daily inhaled corticosteroids for persistent asthma in pediatric patients. This pilot
 study will evaluate a new version of the distance learning program. By using a distance
 learning program rather than a traditional face-to-face educational program, participants
 will be able to complete the program on their own schedule, and this flexibility may result
 in increased interest in the program. The purpose of this study is to evaluate the
 effectiveness of the new distance learning program on changing pediatricians' behavior,
 attitudes, and knowledge regarding the NHLBI guidelines for the use of inhaled
 corticosteroids to treat pediatric patients with asthma.

 This study will enroll pediatricians. Participants will be randomly assigned to either the
 distance learning group or a control group. At baseline, all participants will complete
 questionnaires. Participants in the control group will not take part in any of the
 educational activities. Participants in the distance learning group will take part in a
 1-hour Webinar, or teleconference, that will provide an orientation to the program and
 discuss the importance of the NHLBI guidelines. At any time between the first Webinar and a
 6-week follow-up Webinar, participants will log into the study Web site and complete a
 training module that aims to educate participants on common barriers to prescribing daily
 inhaled corticosteroids. As an alternative to the Web site, participants may choose to view
 the training module on a CD-ROM. Six weeks after the first Webinar, participants will take
 part in a follow-up Webinar. At this time, study researchers will answer participants'
 questions and provide a program review. The Web site and study materials will remain
 available to participants in the distance learning group for 6 months after the follow-up
 Webinar; a list serve will also be made available to participants. At 1 and 6 months after
 the follow-up Webinar, all participants will complete questionnaires.
Inclusion Criteria:

 -  Board-eligible pediatricians involved in direct primary care for children

 -  Has access to a Windows or Macintosh computer with either a CD-ROM drive or Internet
 access

 -  Has access to a telephone for teleconference calls

 -  Willing to take part in the DALI educational seminar if assigned to the intervention
 group